DE602004017201D1 - Nachweis einer histonmodifikation in zellfreien nukleosomen - Google Patents
Nachweis einer histonmodifikation in zellfreien nukleosomenInfo
- Publication number
- DE602004017201D1 DE602004017201D1 DE602004017201T DE602004017201T DE602004017201D1 DE 602004017201 D1 DE602004017201 D1 DE 602004017201D1 DE 602004017201 T DE602004017201 T DE 602004017201T DE 602004017201 T DE602004017201 T DE 602004017201T DE 602004017201 D1 DE602004017201 D1 DE 602004017201D1
- Authority
- DE
- Germany
- Prior art keywords
- cell
- free nucleosomes
- evidence
- nucleosomes
- histone modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Geophysics And Detection Of Objects (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0319376.0A GB0319376D0 (en) | 2003-08-18 | 2003-08-18 | Histone modification detection |
| PCT/GB2004/003564 WO2005019826A1 (en) | 2003-08-18 | 2004-08-18 | Detection of histone modification in cell-free nucleosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004017201D1 true DE602004017201D1 (de) | 2008-11-27 |
Family
ID=28052702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004017201T Expired - Lifetime DE602004017201D1 (de) | 2003-08-18 | 2004-08-18 | Nachweis einer histonmodifikation in zellfreien nukleosomen |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9128086B2 (de) |
| EP (1) | EP1668368B1 (de) |
| AT (1) | ATE411525T1 (de) |
| DE (1) | DE602004017201D1 (de) |
| DK (1) | DK1668368T3 (de) |
| ES (1) | ES2315697T3 (de) |
| GB (1) | GB0319376D0 (de) |
| SI (1) | SI1668368T1 (de) |
| WO (1) | WO2005019826A1 (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| CA2607327A1 (en) * | 2005-04-29 | 2006-11-09 | The Regents Of The University Of California | Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
| US8119572B2 (en) | 2005-10-24 | 2012-02-21 | Wisconsin Alumni Research Foundation | Methods for determining protein binding specificity using peptide libraries |
| WO2012040523A2 (en) | 2010-09-24 | 2012-03-29 | The Rockefeller University | Phosphohistidine analogs |
| GB201115095D0 (en) * | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115099D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| EP3264090B1 (de) | 2011-12-07 | 2022-05-18 | Belgian Volition Srl | Verfahren zur erkennung von nukleosomaddukten |
| GB201303576D0 (en) * | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for predicting therapy efficacy using nucleosome structure biomarkers |
| GB201303575D0 (en) * | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for detecting histone modifications in nucleosomes |
| EP2775304A1 (de) * | 2013-03-07 | 2014-09-10 | Universitätsspital Basel | Verfahren zum Nachweis einer entzündlichen Störung |
| WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| EP3213084B2 (de) | 2014-10-29 | 2023-12-13 | Belgian Volition SPRL | Verfahren zur anreicherung von zirkulierendem tumor-dna |
| GB201518665D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| GB201518674D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for detecting nuleosomes containing histone modifications and variants |
| CN109415431A (zh) | 2016-04-20 | 2019-03-01 | 爱兰细胞技术公司 | 与k180二甲基化h1.0蛋白相关的组合物和方法 |
| TWI726009B (zh) * | 2016-11-28 | 2021-05-01 | 比利時商比利時意志有限公司 | 用親和純化法分析生物樣品中源自腫瘤之無細胞核小體、分離生物樣品中純化之腫瘤dna、檢測生物樣品中源自腫瘤之核小體表觀遺傳表位或在動物或人類受試者中檢測癌症之方法或包括組蛋白h1結合劑之套組之用途 |
| EP4011413A1 (de) | 2017-09-18 | 2022-06-15 | Santersus AG | Verfahren und vorrichtung zur reinigung von blut aus zirkulierender zellfreier dna |
| CN111770761B (zh) | 2017-10-25 | 2024-07-09 | 爱兰细胞技术公司 | H1.0k180me2抗体、其制造方法和用途 |
| GB201721569D0 (en) | 2017-12-21 | 2018-02-07 | Belgian Volition Sprl | Method for the detection and treatment of colorectal adenomas |
| CA3088077A1 (en) * | 2018-01-10 | 2019-07-18 | Epicypher, Inc. | Methods for quantification of nucleosome modifications and mutations at genomic loci and clinical applications thereof |
| CA3091807A1 (en) * | 2018-03-01 | 2019-09-06 | Epicypher, Inc. | Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes |
| CN112119166B (zh) * | 2018-03-13 | 2025-08-22 | 耶路撒冷希伯来大学伊萨姆研发有限公司 | 无细胞dna染色质免疫沉淀的诊断应用 |
| GB2587939B (en) | 2018-04-02 | 2023-06-14 | Grail Llc | Methylation markers and targeted methylation probe panels |
| CN113286881A (zh) | 2018-09-27 | 2021-08-20 | 格里尔公司 | 甲基化标记和标靶甲基化探针板 |
| GB201818963D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Methof for the detection of prostate cancer |
| GB201818965D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Method for the detection of colorectal cancer |
| GB201906201D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Voltion Sprl | Method for the detection of protate cancer |
| GB201906199D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| CN114901832A (zh) | 2019-08-27 | 2022-08-12 | 比利时意志有限责任公司 | 分离循环核小体的方法 |
| GB201912251D0 (en) | 2019-08-27 | 2019-10-09 | Belgian Volition Sprl | Method of isolating circulating nucleosomes |
| EP4435431A3 (de) | 2019-12-02 | 2024-10-16 | Belgian Volition SRL | Verwendung von zellfreien nukleosomen als biomarker |
| MX2022011614A (es) | 2020-03-20 | 2022-10-13 | Belgian Volition Srl | Metodo de triaje utilizando niveles de nucleosomas libres de celulas. |
| WO2022058604A1 (en) | 2020-09-21 | 2022-03-24 | Belgian Volition Srl | Device for inline monitoring of free nucleosomes in blood |
| EP4237850A4 (de) * | 2020-11-02 | 2024-09-18 | Epicypher, Inc. | Verbesserte assays zur quantifizierung von chromatinzielen mittels antikörpergerichtetem enzymabbau |
| TW202238131A (zh) | 2020-11-25 | 2022-10-01 | 比利時商比利時意志有限公司 | 測量無細胞核蛋白染色質片段之方法 |
| TW202238132A (zh) | 2020-12-08 | 2022-10-01 | 比利時商比利時意志有限公司 | 多發性硬化症之診斷方法 |
| TW202242130A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 循環轉錄因子分析 |
| TW202242145A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析 |
| TW202242146A (zh) | 2021-01-13 | 2022-11-01 | 比利時商比利時意志有限公司 | 肺癌的檢測方法 |
| GB202108185D0 (en) | 2021-06-08 | 2021-07-21 | Belgian Volition Sprl | Standardisation of nucleosome assays using biologically derived calibrants |
| GB202108452D0 (en) | 2021-06-14 | 2021-07-28 | Belgian Volition Sprl | Triaging method using cell free nucleosome levels |
| JP2024542996A (ja) | 2021-10-29 | 2024-11-19 | ベルジアン ボリション エスアールエル | 均一系免疫アッセイ法 |
| GB202117799D0 (en) | 2021-12-09 | 2022-01-26 | Belgian Volition Srl | Method for the detection of blood cancer |
| US12053567B2 (en) | 2021-12-27 | 2024-08-06 | Santersus Ag | Method and device for removal of circulating cell free DNA |
| WO2023170298A1 (en) | 2022-03-11 | 2023-09-14 | Belgian Volition Srl | Differential diagnosis method |
| GB202205212D0 (en) | 2022-04-08 | 2022-05-25 | Belgian Volition Sprl | Method for transplant organ health assessment |
| WO2024042210A1 (en) | 2022-08-25 | 2024-02-29 | Belgian Volition Srl | Method for measuring cell free chromatin |
| EP4577835A1 (de) | 2022-08-25 | 2025-07-02 | Belgian Volition SRL | Verfahren zum nachweis von demenz |
| EP4639165A1 (de) | 2022-12-19 | 2025-10-29 | Belgian Volition SRL | Beurteilung biologischer proben zur nukleinsäureanalyse |
| WO2024133225A1 (en) | 2022-12-19 | 2024-06-27 | Belgian Volition Srl | Calibration |
| GB202300607D0 (en) | 2023-01-16 | 2023-03-01 | Belgian Volition Srl | Proteins and methods for isolating circulating nucleosomes |
| GB202303562D0 (en) | 2023-03-10 | 2023-04-26 | Belgian Volition Sprl | Sample collection for liquid biopsy |
| WO2024213795A1 (en) | 2023-04-14 | 2024-10-17 | Belgian Volition Srl | Diagnosis method using cell free nucleosome levels |
| WO2024223947A1 (en) | 2023-04-28 | 2024-10-31 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers of carcinomas |
| GB202307768D0 (en) | 2023-05-24 | 2023-07-05 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers |
| GB202310137D0 (en) | 2023-07-03 | 2023-08-16 | Belgian Volition Srl | Method for the detection of cancer |
| WO2025012440A1 (en) | 2023-07-13 | 2025-01-16 | Belgian Volition Srl | Method for detection of the potential of a body fluid sample to produce extracellular traps |
| WO2025061853A1 (en) | 2023-09-19 | 2025-03-27 | Belgian Volition Srl | Lateral flow test device |
| WO2025093747A1 (en) | 2023-11-02 | 2025-05-08 | Belgian Volition Srl | Novel rapid high-throughput method of netosis induction and inhibition with physiologically relevant molecules |
| WO2025181348A1 (en) | 2024-03-01 | 2025-09-04 | Belgian Volition Srl | Method for determining the origin of circulating dna |
| WO2025253002A1 (en) | 2024-06-07 | 2025-12-11 | Belgian Volition Srl | Sample collection for liquid biopsy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2934299A (en) * | 1998-03-18 | 1999-10-11 | Roche Diagnostics Gmbh | Detection of apoptotic products |
| WO2003014142A2 (en) | 2001-08-03 | 2003-02-20 | University Of Virginia Patent Foundation | Phosphorylated histone h2b as an apoptosis marker |
| CN1606628A (zh) | 2001-11-30 | 2005-04-13 | 辉瑞产品公司 | 检测染色体数量异常细胞的方法 |
| AU2003216291A1 (en) * | 2002-02-20 | 2003-09-09 | Chroma Therapeutics Ltd. | A non-invasive diagnostic test utilizing histone modification markers |
| WO2004080288A2 (en) * | 2003-03-10 | 2004-09-23 | University Of Virginia Patent Foundation | Post-translational modifications of proteins as regulatory switches |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| CA2607327A1 (en) * | 2005-04-29 | 2006-11-09 | The Regents Of The University Of California | Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
-
2003
- 2003-08-18 GB GBGB0319376.0A patent/GB0319376D0/en not_active Ceased
-
2004
- 2004-08-18 DK DK04768123T patent/DK1668368T3/da active
- 2004-08-18 EP EP04768123A patent/EP1668368B1/de not_active Expired - Lifetime
- 2004-08-18 DE DE602004017201T patent/DE602004017201D1/de not_active Expired - Lifetime
- 2004-08-18 AT AT04768123T patent/ATE411525T1/de active
- 2004-08-18 SI SI200430992T patent/SI1668368T1/sl unknown
- 2004-08-18 WO PCT/GB2004/003564 patent/WO2005019826A1/en not_active Ceased
- 2004-08-18 ES ES04768123T patent/ES2315697T3/es not_active Expired - Lifetime
- 2004-08-18 US US10/568,691 patent/US9128086B2/en active Active
-
2015
- 2015-08-03 US US14/816,329 patent/US10408831B2/en not_active Expired - Lifetime
-
2019
- 2019-07-26 US US16/523,096 patent/US20190353653A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2315697T3 (es) | 2009-04-01 |
| GB0319376D0 (en) | 2003-09-17 |
| US10408831B2 (en) | 2019-09-10 |
| US20150330996A1 (en) | 2015-11-19 |
| US9128086B2 (en) | 2015-09-08 |
| EP1668368B1 (de) | 2008-10-15 |
| EP1668368A1 (de) | 2006-06-14 |
| ATE411525T1 (de) | 2008-10-15 |
| WO2005019826A1 (en) | 2005-03-03 |
| US20190353653A1 (en) | 2019-11-21 |
| US20070160989A1 (en) | 2007-07-12 |
| SI1668368T1 (sl) | 2009-04-30 |
| DK1668368T3 (da) | 2009-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004017201D1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
| EP2275815A3 (de) | Verbesserte Immunoassayverfahren | |
| DE60228557D1 (de) | Candida-nachweis | |
| BRPI0618713B8 (pt) | cardiolipina modificada e seus usos | |
| WO2003070894A3 (en) | A non-invasive diagnostic test utilizing histone modification markers | |
| ATE474228T1 (de) | Reagenz für hämoglobinabbau | |
| EP2194380A3 (de) | Nachweis eines Zielantigens ungeachtet der An- oder Abwesenheit eines entsprechenden therapeutischen Antikörpers | |
| BRPI0610092B8 (pt) | métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado | |
| GB2404022B (en) | Competitive assays for the detection of methamphetamine group drugs | |
| DE502005009914D1 (de) | Bestimmung von felinem und caninem probnp | |
| WO2008060376A3 (en) | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer | |
| EP1560025A3 (de) | Marker spezifisch für Diabetes | |
| EP2323059A3 (de) | Systeme und Verfahren zur Vorhersage des Risikos einer rheumatoiden Arthritis | |
| WO2005044989A3 (en) | Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same | |
| WO2008017363A3 (en) | Improved immunoassay involving mutant antigens to reduce unspecific binding | |
| ATE503187T1 (de) | Nachweis eines therapeutischen antikörpers in einem versuchstier | |
| WO2005102938A3 (en) | Antibodies specific for bcr-abl fusion protein and uses thereof | |
| ATE447711T1 (de) | System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices | |
| DE602004001994D1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
| ATE440968T1 (de) | Verfahren zur diagnostizierung von aspirinunverträglichkeit | |
| WO2006124888A3 (en) | Detection of antigen specific immunocomplexes | |
| EP2407787A3 (de) | Verfahren für den Nachweis von L523S-Expression in biologischen Proben | |
| WO2005037056A3 (en) | Method for the detection of a biomolecule in a test sample | |
| Osbak | Contemporary syphilis epidemics: efforts to improve syphilis diagnostics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |